Victory Capital Management
KZR

Victory Capital Management’s Kezar Life Sciences KZR Stock Holding History

Victory Capital Management’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-235,949
Closed -$20.3M – 2658
2022
Q3 		$20.3M Sell
235,949
-41,061
-15% -$3.99M 0.02% 809
2022
Q2 		$22.9M Buy
277,010
+101,739
+58% +$8.97M 0.03% 772
2022
Q1 		$29.1M Buy
175,271
+139,651
+392% +$20M 0.03% 736
2021
Q4 		$5.96M Sell
35,620
-21,202
-37% -$2.39M 0.01% 1286
2021
Q3 		$4.91M Buy
56,822
+13,037
+30% +$863K ﹤0.01% 1334
2021
Q2 		$2.38M Sell
43,785
-2,690
-6% -$153K ﹤0.01% 1580
2021
Q1 		$2.77M Sell
46,475
-1,850
-4% -$108K ﹤0.01% 1544
2020
Q4 		$2.52M Sell
48,325
-8,524
-15% -$474K ﹤0.01% 1449
2020
Q3 		$2.75M Sell
56,849
-1,908
-3% -$91.3K ﹤0.01% 1349
2020
Q2 		$3.04M Sell
58,757
-215,248
-79% -$10.9M ﹤0.01% 1305
2020
Q1 		$11.9M Buy
274,005
+224,460
+453% +$9.13M 0.01% 1026
2019
Q4 		$1.99M Buy
49,545
+3,388
+7% +$104K ﹤0.01% 1511
2019
Q3 		$1.51M Buy
46,157
+12
+0% +$579 ﹤0.01% 1568
2019
Q2 		$3.56M Buy
46,145
+23,711
+106% +$3.69M 0.01% 991
2019
Q1 		$3.98M Sell
22,434
-235
-1% -$46.3K 0.01% 903
2018
Q4 		$5.35M Sell
22,669
-19,850
-47% -$4.85M 0.01% 813
2018
Q3 		$9.1M Sell
42,519
-2,348
-5% -$410K 0.02% 770
2018
Q2 		$7.76M Buy
+44,867
New +$7.83M 0.02% 793

Other funds holding KZR

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Victory Capital Management's KZR Position: Q4 2022 in Review

Victory Capital Management sold out of Kezar Life Sciences (KZR) in Q4 2022, closing a stake of 235,949 shares — an estimated $20.3M sold.

Victory Capital Management first reported a position in KZR in Q2 2018 and held it in 18 quarters. The position peaked at $29.1M in Q1 2022. 123 funds tracked by Wall St. Rank hold KZR as of Q4 2022.

  • Victory Capital Management reported no remaining Kezar Life Sciences position as of Q4 2022 after selling out during the quarter.
  • Victory Capital Management sold 235,949 Kezar Life Sciences shares in Q4 2022, an estimated $20.3M.
  • Victory Capital Management first reported a position in Kezar Life Sciences in Q2 2018 and held it in 18 quarters.
  • Victory Capital Management's Kezar Life Sciences position peaked at $29.1M in Q1 2022.
  • 123 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q4 2022.

Based on Victory Capital Management's 13F filing for Q4 2022, filed 9 Feb 2023.